Anthropic and Adaptyv Bio Launch Protein Design Competition

Overview

Anthropic has announced a strategic partnership with biocomputing company Adaptyv Bio to launch a protein design competition. This collaboration aims to demonstrate the practical potential of AI in the optimization of biomolecules, with both parties jointly conducting experimental validation on over 5,000 design proposals. This marks a critical step toward moving AI-assisted drug discovery from purely computational simulation to wet-lab validation.

Partnership Details and Resource Support

This competition is not limited to software-level challenges; it offers substantial hardware and financial support. Anthropic will provide up to $1 million worth of Claude compute credits to support participating teams in large-scale protein structure prediction and design. Meanwhile, Adaptyv Bio is responsible for funding the experimental validation phase, ensuring that promising designs can advance to the laboratory stage.

To further lower the barrier to entry and accelerate the R&D process, partner Modal has contributed computing resources worth up to $250,000, while DNA synthesis giant Twist Bioscience has provided essential gene synthesis services. This alliance, composed of technology giants and specialized biotech companies, provides participants with complete end-to-end support ranging from algorithm design to physical synthesis.

Competition Challenges and Participation

The competition is open globally, with a theme focused on using AI technology to design novel candidate drugs. Participants will compete across five specific biomedical challenges, covering frontier directions ranging from enhancing enzymatic catalytic efficiency to optimizing antibody affinity. Notably, the competition is free for all to enter, and all experimental results will be made public afterward to promote knowledge sharing within the scientific community.

The core objective of this competition is to clarify the boundaries and potential of current AI protein design models through large-scale experimental validation.

The competition runs from September 28 to October 31, 2026. Interested teams can learn more via Adaptyv’s Proteinbase platform and complete registration through the official documentation link. This initiative not only provides developers with a stage to showcase their technology but also offers valuable data references for the biopharmaceutical industry as it explores concrete paths for AI implementation.